About Justin Stindt Consulting
Justin Stindt Consulting is a consulting firm specializing in Strategy & Market Access advisory services for the pharmaceutical, biotech and medical device industry.
Our key difference is that we deliver specific, in-depth insight on payer resonating evidence to create robust value propositions and strategies.
We have extensive international experience in all major EU markets, the USA, Japan and selected emerging markets.
We operate out of offices in Paris and Cologne and have a global reach through our network of payers, clinical experts and partners.
We are passionate about helping our clients
to ensure patient access to innovative
medicines and technologies.
Our team offers a unique combination of skills and experiences
Market Access / P&R strategies
in many therapeutic areas (CV, oncology, respiratory, vaccines, ...) with broad geographic reach: EU-5, USA, selected emerging markets
Payer and clinical expert engagement
Strong network of payers and clinical experts built and maintained via hundreds of engagements
Uniting cross-functional teams
around a common vision of customer needs to identify the optimal evidence generation program
Commercial analysis skills
to build robust forecasts and assess return on investment of different strategic options and evidence packages
Strategic and operational Marketing
to develop compelling value propositions meeting the needs of payer, patient and prescriber customers
Sales force engagement
Engaging sales teams in delivering operational excellence in segmentation & targeting, call frequency and impactful communication
Justin Stindt
Founder and Managing Director Justin Stindt Consulting
Justin's biography
Driven by the passion of ensuring patient access to innovative medicines and technologies
Justin is the founder and Managing Director of Justin Stindt Consulting. He is advising clients of the pharmaceutical, biotech and medical device industry.
He has developed successful Market Access Strategies in several Market Access Director Roles at GlaxoSmithKline.
Justin has led a cross-functional team to identify phase IIIb/IV trials to substantiate the Payer Value Proposition for a novel respiratory drug which resulted in several additional trials to strengthen the evidence package and improve Market Access and Pricing potential.
He has also launched a new urology drug for which he developed the payer value proposition, pricing & reimbursement strategy, launch sequence and payer engagement plan. This contributed to the drug gaining market access in many challenging situations.
Justin has also developed commercial strategies for early stage assets including aspirational product concept development, forecasting of market potential and indication prioritization.
As Sales and Marketing Director Vaccines GSK France he has managed sales force and marketing teams and contributed to significant sales growth of the vaccine business.
He has led international consulting projects with focus pricing and reimbursement for several of the top 20 global pharmaceutical, biotech and medical device companies as a Senior Consultant at Simon-Kucher & Partners.
Justin has worked with global responsibility in many geographic locations and his roles were based in France, Germany, Spain, the UK and the USA.
He speaks English, French, German and Spanish.